- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BLU
Recent news which mentions BLU
From Benzinga
From Benzinga
BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program
July 12, 2022
Tickers
BLU
From Benzinga
From Benzinga
Merck Coughs Up a Failure With Its "Pipeline in a Product"
February 03, 2022
From Motley Fool
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
‘Diamond-handed HODLers’ of GameStop and AMC take a Monday pummeling from the soft-handed crowd
December 13, 2021
From MarketWatch
Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
December 13, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
December 13, 2021
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
From Benzinga
From InvestorPlace
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
December 13, 2021
From InvestorPlace
From InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
December 13, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
October 14, 2021
From InvestorPlace
3 Biotech Stocks That Surged in September
October 05, 2021
From Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
46 Biggest Movers From Yesterday
September 15, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
September 14, 2021
From Benzinga
Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide
September 14, 2021
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August
September 14, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.